US stocks. Difference in DJI and S&P 500.

  * **Weighting Schemes:** The S&P 500 is **market-cap weighted**, meaning massive trillion-dollar companies dictate its movement. The Dow Jones (DJIA) is **price-weighted**, where a stock's absolute share price—not its overall value—determines its impact.

 * **Technology Dominance:** The S&P 500 is heavily concentrated in high-growth **Information Technology** and communication giants. The Dow features fewer tech names, and their influence is constrained by their stock prices rather than their market size.

 * **Cyclical vs. Growth Tilt:** The S&P 500 leans firmly toward **Growth** sectors. The Dow is structurally tilted toward **Value and Cyclical** sectors, maintaining much heavier relative exposure to stable, blue-chip giants in **Financials**, **Industrials**, and **Health Care**.

 * **Sector Exclusions:** The S&P 500 contains all 11 major sectors. The Dow **explicitly excludes Utilities and Transportation** from its core index, as those are tracked separately by the Dow Jones Utility and Transportation Averages.

 * **Breadth and Diversification:** The S&P 500 offers broad exposure across 500 companies, distributing risk across small and large sector players. The Dow contains just 30 stocks, meaning a single major price swing in an industrial or financial stock can heavily warp the entire index's performance.

 * **Market Cycle Performance:** Because of these differences, a rising market driven by tech innovation favors the S&P 500. Conversely, during a falling market or a rotation into defensive value plays, the Dow's legacy sector focus typically provides more stability.

Comments

Post a Comment

Popular posts from this blog

LT investing. Pharma. How to shortlist stocks to make a balanced portfolio

 Used Gemini. prompts and outputs are given below. My comments are marked 'mk'. This is a single thread. prompt:  what are different types of pharma stocks like cdmo, generic producers etc. in plain text <500 words. output: The pharmaceutical sector is divided into distinct business models based on where companies operate along the drug value chain. Understanding these categories helps clarify how they generate revenue and manage risk. Generics and Branded Generics These companies manufacture exact copies of off-patent chemical drugs. Their business model relies on high-volume, low-cost production to capture market share globally. While demand is steady due to constant patent expirations, they face heavy price erosion from intense competition and strict regulatory audits. Examples include Sun Pharma, Dr. Reddy's, and Teva. Active Pharmaceutical Ingredients (APIs) API manufacturers produce the raw chemical or biological bulk components that give medicines their therapeuti...
Read more

Peter Thiel’s rules

Peter Thiel’s rules emphasize spotting unique, durable businesses rather than chasing cheap valuations. His framework guides investors to focus on philosophy, quality, moats, niche dominance, independent thinking, reinvestment, and long-term conviction.   Ref https://m.economictimes.com/markets/stocks/news/peter-thiels-7-timeless-rules-for-spotting-winning-businesses-here-is-what-investors-must-know/articleshow/133435143.cms --- 📌 Peter Thiel’s Rules Major 3 rules: - Business philosophy     Look beyond financial metrics. Companies built on strong values, clear missions, and disciplined execution create sustainable long‑term value.   - Quality over cheap valuations     Don’t chase low prices. Prioritize strong balance sheets, cash generation, competitive positioning, and capital allocation.   - Durable competitive advantages     Back “creative monopolies” — firms with proprietary tech, network effects, power...
Read more

Major Periods of Notable Pullbacks in Nifty 50

The Nifty 50 index, launched in 1996, has seen numerous pullbacks—temporary declines from recent highs—amid global events, domestic policies, and economic shifts. "Notable" pullbacks here refer to corrections of 10% or more, with a focus on significant ones exceeding 20% (often classified as bear markets). These occur roughly every 2-3 years on average, with historical data showing about 19 such 10%+ corrections in the last 16 years (average depth ~14%) and 8 bear markets in 25 years (average depth 38.5%, lasting ~246 days to bottom). Below is a curated table of key notable pullback periods, primarily bear markets (>20% decline), compiled from reliable historical analyses. I've included peak-to-trough timelines, percentage drawdowns, durations to bottom, and major triggers where known. For brevity, this focuses on the most impactful; smaller 10-20% corrections (e.g., mid-2018 global trade tensions or late-2021 FII outflows) occur annually but are less transformative. P...
Read more